Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hydroxyurea for Sickle Cell Disease Treatment
source: The Ohio State University
year: 2020
summary/abstract:Hydroxyurea is a medicine used to reduce the problems caused by sickle cell disease. Other names for this drug are Droxia and Hydrea. People with sickle cell disease have sickle-shaped red blood cells that can block blood flow. Hydroxyurea increases a type of hemoglobin, called fetal hemoglobin that makes the red blood cells bigger and helps them stay rounder and more flexible.
Hydroxyurea is also used to treat certain types of cancer. The dose of Hydroxyurea is different based on the health condition it is being used to treat.
Why is Hydroxyurea Helpful in Treating Sickle Cell Disease?
Research has shown that taking Hydroxyurea for sickle cell disease lowers the number of:
• Acute chest syndrome events
• Pain crises
• Blood transfusions
• Trips to the hospital
+myBinderRelated Content
-
Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell DiseaseBackground: Hydroxyurea reduces pain cr...
-
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH ...Background: Sickle cell anemia (SCA) i...
-
Is Your Child the Right Candidate for Hydroxyureahttps://www.youtube.com/watch?v=vMvC5rVH...
-
Hydroxyurea improves lung function in children with sickle cell diseaseFor the first time, researchers were abl...
-
FDA Approves Hydroxyurea Tablets for Pediatric Patients With Sickle Cell AnemiaThe US Food and Drug Administration (FDA...
-
Sickle Cell Disease, Hydroxyurea: What You Should Knowhttps://www.onescdvoice.com/wp-content/u...
-
Hydroxyurea Treatment in Men with SCA Leads to Drop in Total Sperm Count, Study ShowsResearchers found that treatment with hy...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.